drugs

Catalan Oncology Institute will pay Roche drugs depending on clinical results

January 24, 2014 07:47 PM | ACN

The Catalan Institute of Oncology (ICO) and Roche pharmaceutical company have signed an agreement stating that the Catalan public institute will pay for treatments against cancer depending on clinical results adapted to each specific patient. For now, the agreement provides that Roche will supply two drugs against the most common cancers, mostly breast and colon. According to the agreement, the probabilities of success will be thoroughly examined and if they meet the requirements, the Catalan Government will fully pay for the treatment. If not, Roche will assume the costs progressively according to the degree of success.

Catalan Police’s largest-ever operation ends with 33 drug dealers arrested

November 15, 2013 09:18 PM | ACN / Lluís Vilaró

The extensive Catalan Police operation against drug trafficking in Barcelona’s Zona Franca quarter and in Sant Adrià de Besós’ (North of Barcelona) ‘La Mina’ neighbourhood resulted in 33 arrests and 29 homes searched. With 300 police officers deployed from 7 different police areas, this operation was the largest-ever made by the Catalan Government’s police corps in terms of officers deployed. Catalan Minister for Home Affairs, Ramon Espadaler, stated that further arrests could still be announced in the following days. The investigation leading to this operation had begun in December 2012.

Pharmaceutical spending drops by 24.6% in Catalonia in July

August 27, 2012 11:28 PM | CNA

Compared to a year ago, the Catalan Healthcare System spent 24.6% less last July than in the same month of 2011. In July 2011, Catalonia spent €143.52 million on pharmaceutical products while it spent €108.10 million last month, when the drug prescription fee began and citizens started to pay a greater share of the cost of prescription drugs. Furthermore, drug prescriptions fell by 20%. In the whole of Spain, pharmaceutical spending also decreased by 24% last July, compared to a year ago.

The Catalan Health Minister warns that not subsidising 417 drugs may increase health spending

August 17, 2012 11:21 PM | CNA / Guillem Sánchez

The Spanish Social Security has published the list with the 417 drugs that from September will no longer be subsidised in order to reduce public spending and meet deficit targets. Most of them are some of the most consumed medicines for minor symptoms, such as heartburn, muscle pain, or diarrhoea. Since the measure is not popular among doctors, the Catalan Health Minister, Boi Ruiz, said that more expensive drugs with similar effects but not included in the list may now be prescribed, which would increase pubic healthcare spending instead of reducing it.

Grifols makes net profit of €133.5 million in the first half of 2012

July 31, 2012 07:42 PM | CNA / David Tuxworth

The Catalan pharmaceutical company Grifols, the third world leader in the production of blood plasma based technologies, has seen its turnover increase by 15% in the first half of 2012 to €1.32 billion. Its net profit for the first half of 2012 was €133.5 million, seven times that of the previous year. The company’s success is attributed to its wide geographical consumer base and the recent purchase of US based Talecris Plasma Resources.

The police would act against Rasquera’s cannabis plantation

April 11, 2012 11:07 PM | CNA

Rasquera, with less than one-thousand residents and located in southern Catalonia, approved on April 10th planting cannabis as part of their local economic reactivation plan through a citizen vote. The day after, Rasquera’s Mayor announced he will resign as his proposal did not reach 75% of the popular support. However, he said the plan will carry on. The Catalan Minister for Home Affairs affirmed that the police will report to the public attorney on any cannabis plantation, since they continue being illegal despite Rasquera’s vote. The Spanish Justice Minister thought that the initiative could have “more negative consequences in the long run” than “positive in the short term”.